Understanding the Risks of Investing in Fulcrum Therapeutics Inc (FULC)
Fulcrum Therapeutics Inc’s recently made public that its Vice President, Finance Tourangeau Greg unloaded Company’s shares for reported $57219.0 on Mar 08 ’24. In the deal valued at $11.72 per share,4,884 shares were sold. As a result of this transaction, Tourangeau Greg now holds 11,807 shares worth roughly $87489.87. Then, Sapir Alex bought 43,360 shares, […]
FULC short interest fall by -34.73%, reflecting positive sentiment
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Fulcrum Therapeutics Inc shares valued at $57,219 were sold by Tourangeau Greg on Mar 08 ’24. At $11.72 per share, Tourangeau Greg sold 4,884 shares. The insider’s holdings dropped to 11,807 […]
Fulcrum Therapeutics Inc (FULC) receives an Outperform rating from RBC Capital Mkts
In a filing, Fulcrum Therapeutics Inc revealed its Vice President, Finance Tourangeau Greg unloaded Company’s shares for reported $57219.0 on Mar 08 ’24. In the deal valued at $11.72 per share,4,884 shares were sold. As a result of this transaction, Tourangeau Greg now holds 11,807 shares worth roughly $99769.15. Then, Sapir Alex bought 43,360 shares, […]
FULC’s short interest shows a sharp decline on Mar 15, 2024
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Fulcrum Therapeutics Inc shares valued at $57,219 were sold by Tourangeau Greg on Mar 08 ’24. At $11.72 per share, Tourangeau Greg sold 4,884 shares. The insider’s holdings dropped to 11,807 shares worth approximately $0.11 million following […]
Fulcrum Therapeutics Inc [FULC] Investment Appeal on the Rise
In a filing, Fulcrum Therapeutics Inc revealed its Vice President, Finance Tourangeau Greg unloaded Company’s shares for reported $57219.0 on Mar 08 ’24. In the deal valued at $11.72 per share,4,884 shares were sold. As a result of this transaction, Tourangeau Greg now holds 11,807 shares worth roughly $0.11 million. Then, Sapir Alex bought 43,360 […]
Understanding the Risks of Investing in Fulcrum Therapeutics Inc (FULC)
Fulcrum Therapeutics Inc’s recent filing unveils that its Vice President, Finance Tourangeau Greg unloaded Company’s shares for reported $57219.0 on Mar 08 ’24. In the deal valued at $11.72 per share,4,884 shares were sold. As a result of this transaction, Tourangeau Greg now holds 11,807 shares worth roughly $0.11 million. Then, Sapir Alex bought 43,360 […]
